BUSINESS INFORM №5-2016

The title and content

ABSTRACTS AND INFORMATION ABOUT AUTHORS

32

Section: Management and Marketing
UDC 615.1:65.01
Zoidze D. R.
The Main Directions of Crisis Management at the Enterprises of Pharmaceutical Industry (p. 207 - 213)
The article is aimed at studying the basic directions of crisis management at the enterprises of pharmaceutical industry. The basic directions of a comprehensive anti-crisis program for pharmaceutical enterprises ahve been determined. It has been proposed to include the risk management for quality into the anti-crisis measures at the enterprises of pharmaceutical industry. The mechanism for financial stabilization depending on the phase of financial crisis has been considered. A scientific approach to carrying out the re-engineering of the pharmaceutical business has been systematized and generalized. It is recommended to use the domestic and foreign outsourcing as a tool for the restructuring of pharmaceutical enterprise. Benefits of the innovation outsourcing for economic entities in the pharmaceutical market have been clarified. Use of outstaffing as a means to reduce the cost of enterprise in crisis conditions has been analyzed. Prospect for further research in this direction is identifying the factors that hinder the process of crisis management and impede the sustainable economic development of the enterprises of pharmaceutical industry.
Keywords: crisis management, quality risk management, crisis PR, reengineering of business processes, joint service center, innovative outsourcing, outstaffing
Fig.: 5. Tabl.: 1. Bibl.: 16.

Zoidze Diana R. – Candidate of Sciences (Economics), Associate Professor, Associate Professor, Department of Management and Public Administration, National Pharmaceutical University (53 Pushkіnska Str., Kharkіv, 61002, Ukraine)
Email: [email protected]

Article is written in Ukrainian
Downloads/views: 3

Download article (pdf) -

Reference to this article:
Zoidze, Diana R. (2016) “The Main Directions of Crisis Management at the Enterprises of Pharmaceutical Industry.” Business Inform 5:207–213.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |

FOR AUTHORS

License Contract

Conditions of Publication

Article Requirements

Regulations on Peer-Reviewing

Publication Contract

Current Issue

Frequently asked questions

INFORMATION

The Plan of Scientific Conferences

OUR PARTNERS

Journal «The Problems of Economy»

The site and its metadata are licensed under CC BY-SA.

Write to webmaster